Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma

Clin Adv Hematol Oncol. 2012 Apr;10(4):266-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Female
  • Humans
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology*
  • Plasma Cells / drug effects
  • Plasma Cells / pathology
  • Pyrazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib